Se connecter Inscription gratuite

Kazia Therapeutics Ret. sur les actifs

Quel est le Ret. sur les actifs de Kazia Therapeutics?

Le Ret. sur les actifs de Kazia Therapeutics Limited est -33.41%

Quelle est la définition de Ret. sur les actifs?



Le rendement des actifs indique dans quelle mesure les actifs d'une entreprise génèrent des revenus. Il est calculé en divisant le résultat net par l'actif total moyen.

The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.

Ret. sur les actifs des entreprises dans Health Care secteur sur ASX par rapport à Kazia Therapeutics

Que fait Kazia Therapeutics?

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.

Entreprises avec ret. sur les actifs similaire à Kazia Therapeutics